Hematopoietic progenitor cell populations having affinity for E-selectin / L-selectin
US10370642B2 · kind B2 · utility
0Cited by
13References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 16, 2015 |
| Grant date | Aug 6, 2019 |
| Priority date | — |
| Expiry date | Mar 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention feature methods and compositions for treating hematopoietic disorders, inflammatory conditions, and cancer and providing stem cell therapy in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.